Maintaining muscle mass when youre losing weight is about getting enough aerobic and resistance exercise every week, studies of people who have undergone bariatric weight-loss surgery have shown
In March 2025, Roche and Zealand Pharma launched an Up-to-$5.3B obesity collaboration to co-develop and co-commercialize Zealands petrelintide for overweight and obesity indications
Consumers should understand that marketing claims for these products often lack rigorous clinical validation
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda) follow gradual dose-escalation protocols to minimize side effects while achieving therapeutic goals
However, the contribution of GLP-1 to insulin stimulation was likely modest, and further evaluation using a GLP-1 receptor antagonist would be necessary
Markets and Markets